Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
Authors
Keywords
-
Journal
CANCER
Volume 118, Issue 21, Pages 5424-5431
Publisher
Wiley
Online
2012-05-09
DOI
10.1002/cncr.27533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results
- (2014) C. Louis et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
- (2011) Judith Meza-Junco et al. CANCER TREATMENT REVIEWS
- Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma
- (2011) David L. Andolino et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
- (2010) Jiwei Huang et al. ANNALS OF SURGERY
- Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
- (2010) Jung Hyun Kwon et al. BMC CANCER
- Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
- (2010) Higinia R. Cárdenes et al. Clinical & Translational Oncology
- Gastroduodenal Complications After Concurrent Chemoradiation Therapy in Patients With Hepatocellular Carcinoma: Endoscopic Findings and Risk Factors
- (2010) Young Eun Chon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma
- (2010) Young Seok Seo et al. JOURNAL OF SURGICAL ONCOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Predictors of Survival After Resection of Retroperitoneal Sarcoma
- (2009) Hari Nathan et al. ANNALS OF SURGERY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population
- (2008) Roderich E. Schwarz et al. AMERICAN JOURNAL OF SURGERY
- Observation of a Dose–Control Relationship for Lung and Liver Tumors After Stereotactic Body Radiation Therapy
- (2008) Robert McCammon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2008) Regina V. Tse et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe
- (2008) Mitsuhiro Nakamura et al. MEDICAL PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started